EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dendritic Cells in Cancer Immunology and Immunotherapy

Laura Hato, Angel Vizcay iD, Iñaki Eguren, José L Pérez-Gracia iD, Javier Rodríguez iD, Jaime Gállego Pérez-Larraya iD, Pablo Sarobe iD, Susana Inogés, Ascensión López Díaz de Cerio, Marta Santisteban iD

Cancers · 28.02.2024 · 16 (5) · 981

DOI: 10.3390/cancers16050981 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.02.2024. Verfasst von Laura Hato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunology, Riberalab, 03203 Alicante, Spain. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy modulates the immune system, overcomes immune escape and stimulates immune defenses against tumors. Dendritic cells (DCs) are professional promoters of immune responses against tumor antigens with the outstanding ability to coordinate the innate and adaptive immune systems. Evidence suggests that there is a decrease in both the number and function of DCs in cancer patients. Therefore, they represent a strong scaffold for therapeutic interventions. DC vaccination (DCV) is safe, and the antitumoral responses induced are well established in solid tumors. Although the addition of checkpoint inhibitors (CPIs) to chemotherapy has provided new options in the treatment of cancer, they have shown no clinical benefit in immune desert tumors or in those tumors with dysfunctional or exhausted T-cells. In this way, DC-based therapy has demonstrated the ability to modify the tumor microenvironment for immune enriched tumors and to potentiate systemic host immune responses as an active approach to treating cancer patients. Application of DCV in cancer seeks to obtain long-term antitumor responses through an improved T-cell priming by enhancing previous or generating de novo immune responses. To date, DCV has induced immune responses in the peripheral blood of patients without a significant clinical impact on outcome. Thus, improvements in vaccines formulations, selection of patients based on biomarkers and combinations with other antitumoral therapies are needed to enhance patient survival. In this work, we review the role of DCV in different solid tumors with their strengths and weaknesses, and we finally mention new trends to improve the efficacy of this immune strategy.

Schlagwörter

Stichwörter der Autor:innen

cancerdendritic cellimmunotherapyvaccine

Autor:innen und Institutionen

  • Immunology, Riberalab, 03203 Alicante, Spain.
  • Medical Oncology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
  • IdiSNA, Instituto de Investigación Sanitaria de Navarra, 31008 Pamplona, Spain.
  • Neurology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
  • Program of Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, 31008 Pamplona, Spain.
  • CIBEREHD, 31008 Pamplona, Spain.

ORCID-Profile: Angel Vizcay, José L Pérez-Gracia, Javier Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Marta Santisteban

Zitieren

APA

Hato, L., Vizcay, A., Eguren, I., Pérez-Gracia, J. L., Rodríguez, J., Gállego Pérez-Larraya, J., Sarobe, P., Inogés, S., Díaz de Cerio, A. L., & Santisteban, M. (2024). Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers, 16(5), 981. https://doi.org/10.3390/cancers16050981

Vancouver

Hato L, Vizcay A, Eguren I, Pérez-Gracia JL, Rodríguez J, Gállego Pérez-Larraya J, et al. Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers. 2024;16(5):981. doi:10.3390/cancers16050981

BibTeX
@article{Hato2024,
  author = {Hato, Laura and Vizcay, Angel and Eguren, Iñaki and Pérez-Gracia, José L and Rodríguez, Javier and Gállego Pérez-Larraya, Jaime and Sarobe, Pablo and Inogés, Susana and Díaz de Cerio, Ascensión López and Santisteban, Marta},
  title = {Dendritic Cells in Cancer Immunology and Immunotherapy},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {981},
  doi = {10.3390/cancers16050981}
}
Kostenlos starten →